Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

BACKGROUND: Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pataky, Reka, Armstrong, Linlea, Chia, Stephen, Coldman, Andrew J, Kim-Sing, Charmaine, McGillivray, Barbara, Scott, Jenna, Wilson, Christine M, Peacock, Stuart
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711845/
https://ncbi.nlm.nih.gov/pubmed/23837641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados